REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Form 10-Q — May 13, 2026
Reviva Pharmaceuticals Holdings, Inc. (RVPH) completed a 1-for-20 reverse stock split on March 9, 2026. This split did not change the number of authorized shares or par value but did result in a reduction of outstanding shares from 5,872,865 to 12,810,377. The company also raised $10.0 million in gross proceeds from a public offering on March 20, 2026, with net proceeds of $8.9 million after deducting placement agent fees and other offering expenses.
Key figures
- Eps
- -0.46
- Eps Beat
- 0
- Revenue
- 0
- Net Income
- -3,195,987
- Total Debt
- 231,274
- Debt Amount
- 231,274
- Revenue Yoy
- 0
- Total Assets
- 23,559,636
- Cash Position
- 22,190,231
- Deal Value Usd
- 0
- Interest Rate
- 7.15%
- Maturity Date
- October 2026
- Gross Proceeds
- 10,000,000
- Offering Price
- 1.50
- Shares Offered
- 6,283,334
- Shares Outstanding
- 12,810,377
- Reverse split ratio
- 1:20
Price after filing
1 day: 0.0%7 days: 0.0%30 days: +94.2%
Close on the filing date to close N calendar days later (from $0.35). Historical, not a forecast.
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.